We expect the near-term outlook to remain subdued due to continued delays in JJM project payments and challenges in working capital management. However, the strong order book and healthy traction in new project awards provide good revenue visibility. We project a revenue CAGR of 9% over FY25FY27, with a meaningful recovery expected from H2FY26. We maintain BUY rating and value NCC at 11x...